AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine

References

• Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139–e596. doi:10.1161/CIR.0000000000000757
   PubMed Web of Science ®Google Scholar
• Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11. doi:10.15420/cfr.2016:25:2
   PubMedGoogle Scholar
• Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American heart association [published correction appears in Circulation. 2022 Sep 6;146(10):e141]. Circulation. 2022;145(8):e153–e639. doi:10.1161/CIR.0000000000001052
   PubMed Web of Science ®Google Scholar
• Niskanen JE, Ohlsson Å, Ljungvall I, et al. Identification of novel genetic risk factors of dilated cardiomyopathy: from canine to human. Genome Med. 2023;15(1):73. doi:10.1186/s13073-023-01221-3
   PubMed Web of Science ®Google Scholar
• Zhou J, Luo Y, Kang X, Bian F, Liu D. The root extract of Scutellaria baicalensis Georgi promotes β cell function and protects from apoptosis by inducing autophagy. J Ethnopharmacol. 2022;284:114790. doi:10.1016/j.jep.2021.114790
   PubMed Web of Science ®Google Scholar
• Burchill LJ, Lee MGY, Nguyen VP, Stout KK. Heart failure in adult congenital heart disease. Cardiol Clin. 2020;38(3):457–469. doi:10.1016/j.ccl.2020.04.010
   PubMed Web of Science ®Google Scholar
• Goldstein D, Frishman WH. Diastolic heart failure: a review of current and future treatment options. Cardiol Rev. 2021;29(2):82–88. doi:10.1097/CRD.0000000000000303
   PubMed Web of Science ®Google Scholar
• Kim AH, Jang JE, Han J. Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy. Biomed Pharmacother. 2022;145:112463. doi:10.1016/j.biopha.2021.112463
   PubMed Web of Science ®Google Scholar
• MacDonald BJ, Virani SA, Zieroth S, Turgeon R. Heart failure management in 2023: a pharmacotherapy- and lifestyle-focused comparison of current international guidelines. CJC Open. 2023;5(8):629–640. doi:10.1016/j.cjco.2023.05.008
   PubMedGoogle Scholar
• Kim J, Yang G, Kim Y, Kim J, Ha J. AMPK activators: mechanisms of action and physiological activities. Exp Mol Med. 2016;48(4):e224. doi:10.1038/emm.2016.16
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhou XE, Xu HE, Melcher K. Structure and physiological regulation of AMPK. Int J Mol Sci. 2018;19(11):3534. doi:10.3390/ijms19113534
   PubMed Web of Science ®Google Scholar
• Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121–135. doi:10.1038/nrm.2017.95
   PubMed Web of Science ®Google Scholar
• Sanli T, Steinberg GR, Singh G, Tsakiridis T. AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol Ther. 2014;15(2):156–169. doi:10.4161/cbt.26726
   PubMed Web of Science ®Google Scholar
• Xiao B, Sanders MJ, Underwood E, et al. Structure of mammalian AMPK and its regulation by ADP. Nature. 2011;472(7342):230–233. doi:10.1038/nature09932
   PubMed Web of Science ®Google Scholar
• Li X, Liu J, Lu Q, et al. AMPK: a therapeutic target of heart failure-not only metabolism regulation. Biosci Rep. 2019;39(1):BSR20181767. doi:10.1042/BSR20181767
   PubMedGoogle Scholar
• Wu S, Zou MH. AMPK, mitochondrial function, and cardiovascular disease. Int J Mol Sci. 2020;21(14):4987. doi:10.3390/ijms21144987
   PubMed Web of Science ®Google Scholar
• Wen Y, Kunjian H, Li O, Xiaoyue C, Yingqiang Z. Mechanism of adenylate-activated protein kinase in the prevention and control of heart failure and progress of intervention in traditional Chinese medicine. Liaoning J Chin Med. 2023;50(04):212–216.
   Google Scholar
• Yaqi H, Jianhe L. Progress of Chinese medicine in regulating AMPK signalling pathway for the treatment of myocardial ischemia-reperfusion injury. Chin J Exp Formulas. 2023;29(13):213–221.
   Google Scholar
• Yu S, Qian H, Tian D, et al. Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction. Front Pharmacol. 2023;14:1074837. doi:10.3389/fphar.2023.1074837
   PubMed Web of Science ®Google Scholar
• Ge Y, Zhou M, Chen C, Wu X, Wang X. Role of AMPK mediated pathways in autophagy and aging. Biochimie. 2022;195:100–113. doi:10.1016/j.biochi.2021.11.008
   PubMed Web of Science ®Google Scholar
• Hardie DG, Schaffer BE, Brunet A. AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol. 2016;26(3):190–201. doi:10.1016/j.tcb.2015.10.013
   PubMed Web of Science ®Google Scholar
• Hardie DG. AMPK--sensing energy while talking to other signaling pathways. Cell Metab. 2014;20(6):939–952. doi:10.1016/j.cmet.2014.09.013
   PubMed Web of Science ®Google Scholar
• Xiao B, Heath R, Saiu P, et al. Structural basis for AMP binding to mammalian AMP -activated protein kinase. Nature. 2007;449(7161):496–500. doi:10.1038/nature06161
   PubMed Web of Science ®Google Scholar
• Hardie DG, Carling D, Gamblin SJ. AMP-activated protein kinase: also regulated by ADP? Trends Biochem Sci. 2011;36(9):470–477. doi:10.1016/j.tibs.2011.06.004
   PubMed Web of Science ®Google Scholar
• Garcia D, Shaw RJ. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell. 2017;66(6):789–800. doi:10.1016/j.molcel.2017.05.032
   PubMed Web of Science ®Google Scholar
• Timm KN, Tyler DJ. The role of AMPK activation for cardioprotection in doxorubicin-induced cardiotoxicity. Cardiovasc Drugs Ther. 2020;34(2):255–269. doi:10.1007/s10557-020-06941-x
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu S, Zhai A, Zhang B, Tian G. AMPK-mediated regulation of lipid metabolism by phosphorylation. Biol Pharm Bull. 2018;41(7):985–993. doi:10.1248/bpb.b17-00724
   PubMed Web of Science ®Google Scholar
• Qiu Z, Li Y, Fu Y, Yang Y. Research progress of AMP-activated protein kinase and cardiac aging. Open Life Sci. 2023;18(1):20220710. doi:10.1515/biol-2022-0710
   PubMed Web of Science ®Google Scholar
• Wu ZZ, Rao M, Xu S, Hu HY, Tang QZ. Coumestrol ameliorates doxorubicin-induced cardiotoxicity via activating AMPKα. Free Radic Res. 2020;54(8–9):629–639. doi:10.1080/10715762.2020.1822525
   PubMed Web of Science ®Google Scholar
• Kurose H. Cardiac fibrosis and fibroblasts. Cells. 2021;10(7):1716. doi:10.3390/cells10071716
   PubMed Web of Science ®Google Scholar
• Díez J, De Boer RA. Management of cardiac fibrosis is the largest unmet medical need in heart failure. Cardiovasc Res. 2022;118(2):e20–e22. doi:10.1093/cvr/cvab228
   PubMed Web of Science ®Google Scholar
• Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J Mol Cell Cardiol. 2011;51(4):600–606. doi:10.1016/j.yjmcc.2010.10.033
   PubMed Web of Science ®Google Scholar
• Desmouliere A, Geinoz A, Gabbiani F, et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122(1):103–111. doi:10.1083/jcb.122.1.103
   PubMed Web of Science ®Google Scholar
• Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71(4):549–574. doi:10.1007/s00018-013-1349-6
   PubMed Web of Science ®Google Scholar
• Zhang YE. Non-Smad Signaling Pathways of the TGF-beta Family. Cold Spring Harb Perspect Biol. 2017;9(2):647–691. doi:10.1101/cshperspect.a022129
   Web of Science ®Google Scholar
• Chen R, Feng Y, Wu J, et al. Metformin attenuates angiotensin II-induced TGFbeta1 expression by targeting hepatocyte nuclear factor-4-alpha. Br J Pharmacol. 2018;175(8):1217–1229. doi:10.1111/bph.13753
   PubMed Web of Science ®Google Scholar
• Du J, Guan T, Zhang H, et al. Inhibitory crosstalk between ERK and AMPK in the growth and proliferation of cardiac fibroblasts. Biochem Biophys Res Commun. 2008;368(2):402–407. doi:10.1016/j.bbrc.2008.01.099
   PubMed Web of Science ®Google Scholar
• Chen X, Li X, Zhang W, et al. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-kappaB pathway. Metabolism. 2018;83(256):256–270. doi:10.1016/j.metabol.2018.03.004
   PubMedGoogle Scholar
• Oh CM, Ryu D, Cho S, Jang Y. Mitochondrial quality control in the heart: new drug targets for cardiovascular disease. Korean Circ J. 2020;50(5):395–405. doi:10.4070/kcj.2019.0416
   PubMed Web of Science ®Google Scholar
• Gupta A, Chacko VP, Schär M, Akki A, Weiss RG. Impaired ATP kinetics in failing in vivo mouse heart. Circ Cardiovasc Imaging. 2011;4(1):42–50. doi:10.1161/CIRCIMAGING.110.959320
   PubMed Web of Science ®Google Scholar
• Gibbs CL, Loiselle DS. Cardiac basal metabolism. Jpn J Physiol. 2001;51(4):399–426. doi:10.2170/jjphysiol.51.399
   PubMedGoogle Scholar
• Wasyluk W, Nowicka-Stążka P, Zwolak A. Heart metabolism in sepsis-induced cardiomyopathy-unusual metabolic dysfunction of the heart. Int J Environ Res Public Health. 2021;18(14):7598. doi:10.3390/ijerph18147598
   PubMed Web of Science ®Google Scholar
• Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol. 2004;555(Pt 1):1–13. doi:10.1113/jphysiol.2003.055095
   PubMed Web of Science ®Google Scholar
• Feng Y, Zhang Y, Xiao H. AMPK and cardiac remodelling. Sci China Life Sci. 2018;61(1):14–23. doi:10.1007/s11427-017-9197-5
   PubMed Web of Science ®Google Scholar
• Ng SM, Neubauer S, Rider OJ. Myocardial Metabolism in Heart Failure. Curr Heart Fail Rep. 2023;20(1):63–75. doi:10.1007/s11897-023-00589-y
   PubMed Web of Science ®Google Scholar
• Yang J, Holman GD. Insulin and contraction stimulate exocytosis, but increased AMP-activated protein kinase activity resulting from oxidative metabolism stress slows endocytosis of GLUT4 in cardiomyocytes. J Biol Chem. 2005;280(6):4070–4078. doi:10.1074/jbc.M410213200
   PubMed Web of Science ®Google Scholar
• Wolfgang MJ, Kurama T, Dai Y, et al. The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc Natl Acad Sci U S A. 2006;103(19):7282–7287. doi:10.1073/pnas.0602205103
   PubMed Web of Science ®Google Scholar
• Dyck JR, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol. 2006;574(Pt 1):95–112. doi:10.1113/jphysiol.2006.109389
   PubMed Web of Science ®Google Scholar
• Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006;27(7):728–735. doi:10.1210/er.2006-0037
   PubMed Web of Science ®Google Scholar
• Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev. 2008;29(6):677–696. doi:10.1210/er.2008-0017
   PubMed Web of Science ®Google Scholar
• Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr. 2011;93(4):884S–90. doi:10.3945/ajcn.110.001917
   PubMed Web of Science ®Google Scholar
• Khan SU, Khan SU, Suleman M, et al. Natural allies for heart health: nrf2 activation and cardiovascular disease management [published online ahead of print, 2023 Sep 13]. Curr Probl Cardiol. 2023;49(1 Pt B):102084. doi:10.1016/j.cpcardiol.2023.102084
   PubMedGoogle Scholar
• Guo S, Yao Q, Ke Z, Chen H, Wu J, Liu C. Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Mol Cell Endocrinol. 2015;412:85–94. doi:10.1016/j.mce.2015.05.034
   PubMed Web of Science ®Google Scholar
• Xu L, Wang S, Li B, Sun A, Zou Y, Ge J. A protective role of ciglitazone in ox-LDL-induced rat microvascular endothelial cells via modulating PPARγ-dependent AMPK/eNOS pathway. J Cell Mol Med. 2015;19(1):92–102. doi:10.1111/jcmm.12463
   PubMed Web of Science ®Google Scholar
• Junlong W, Huiyu J, Zhihai F, et al. Research progress of Chinese medicine in regulating AMPK signalling pathway against obese type 2 diabetes[J/OL]. Chin J Exp Formulary. 2023:1–9. doi:10.1111/jcmm.12463
   Google Scholar
• Hardie DG. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology. 2003;144(12):5179–5183. doi:10.1210/en.2003-0982
   PubMed Web of Science ®Google Scholar
• Barreto-Torres G, Parodi-Rullán R, Javadov S. The role of PPARα in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia/reperfusion in rats. Int J Mol Sci. 2012;13(6):7694–7709. doi:10.3390/ijms13067694
   PubMed Web of Science ®Google Scholar
• Liu XD, Li YG, Wang GY, et al. Metformin protects high glucose-cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK signaling pathway. Mol Med Rep. 2020;22(6):5262–5270. doi:10.3892/mmr.2020.11599
   PubMed Web of Science ®Google Scholar
• Barreto-Torres G, Hernandez JS, Jang S, et al. The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARα-cyclophilin D interaction in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2015;308(7):H749–H758. doi:10.1152/ajpheart.00414.2014
   PubMed Web of Science ®Google Scholar
• Cocco G, Jerie P, Amiet P, Pandolfi S. Inflammation in Heart Failure: known knowns and unknown unknowns. Expert Opin Pharmacother. 2017;18(12):1225–1233. doi:10.1080/14656566.2017.1351948
   PubMed Web of Science ®Google Scholar
• Bazoukis G, Stavrakis S, Armoundas AA. Vagus Nerve Stimulation and Inflammation in Cardiovascular Disease: a State-of-The-Art Review [published online ahead of print, 2023 Sep 18]. J Am Heart Assoc. 2023;12(19):e030539. doi:10.1161/JAHA.123.030539
   PubMed Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: from Inflammation to Fibrosis. Circ Res. 2016;119(1):91–112. doi:10.1161/CIRCRESAHA.116.303577
   PubMed Web of Science ®Google Scholar
• Koyani CN, Plastira I, Sourij H, et al. Empagliflozin protects heart from inflammation and energy depletion via AMPK activation. Pharmacol Res. 2020;158:104870. doi:10.1016/j.phrs.2020.104870
   PubMed Web of Science ®Google Scholar
• Zhang Y, He Y, Liu S, et al. SGLT2 inhibitors in aging-related cardiovascular disease: a review of potential mechanisms [published online ahead of print, 2023 Aug 24]. Am J Cardiovasc Drugs. 2023. doi:10.1007/s40256-023-00602-8
   Web of Science ®Google Scholar
• Meng Z, Liu X, Li T, et al. The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway. Int Immunopharmacol. 2021;94:107492. doi:10.1016/j.intimp.2021.107492
   PubMed Web of Science ®Google Scholar
• Zhang L, Tian J, Diao S, Zhang G, Xiao M, Chang D. GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction. Chem Biol Interact. 2020;332:109252. doi:10.1016/j.cbi.2020.109252
   PubMed Web of Science ®Google Scholar
• Pei C, Zhang Y, Wang P, et al. Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-κB and AMPK signaling pathways. Phytother Res. 2019;33(2):294–308. doi:10.1002/ptr.6217
   PubMed Web of Science ®Google Scholar
• Packer M. Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs. Cardiovasc Diabetol. 2020;19(1):62. doi:10.1186/s12933-020-01041-4
   PubMed Web of Science ®Google Scholar
• Kubli DA, Gustafsson AB. Cardiomyocyte health: adapting to metabolic changes through autophagy. Trends Endocrinol Metab. 2014;25(3):156–164. doi:10.1016/j.tem.2013.11.004
   PubMed Web of Science ®Google Scholar
• Gurusamy N, Lekli I, Mukherjee S, et al. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res. 2010;86(1):103–112. doi:10.1093/cvr/cvp384
   PubMed Web of Science ®Google Scholar
• Li Y, Chen C, Yao F, et al. AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1. Arch Biochem Biophys. 2014;558(79):79–86. doi:10.1016/j.abb.2014.06.023
   PubMedGoogle Scholar
• Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214–226. doi:10.1016/j.molcel.2008.03.003
   PubMed Web of Science ®Google Scholar
• Zheng Q, Zhao K, Han X, et al. Inhibition of AMPK accentuates prolonged caloric restriction-induced change in cardiac contractile function through disruption of compensatory autophagy. Biochim Biophys Acta. 2015;1852(2):332–342. doi:10.1016/j.bbadis.2014.04.023
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141. doi:10.1038/ncb2152
   PubMed Web of Science ®Google Scholar
• Liu L, Wang C, Lin Y, et al. Suppression of calcium-sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy. Mol Med Rep. 2016;14(1):111–120. doi:10.3892/mmr.2016.5279
   PubMed Web of Science ®Google Scholar
• Schips TG, Wietelmann A, Hohn K, et al. FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model. Cardiovasc Res. 2011;91(4):587–597. doi:10.1093/cvr/cvr144
   PubMed Web of Science ®Google Scholar
• Wang S, Binder P, Fang Q, et al. Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets. Br J Pharmacol. 2018;175(8):1293–1304. doi:10.1111/bph.13888
   PubMed Web of Science ®Google Scholar
• Wei J, Fang D. Endoplasmic reticulum stress signaling and the pathogenesis of hepatocarcinoma. Int J Mol Sci. 2021;22(4):1799. doi:10.3390/ijms22041799
   PubMed Web of Science ®Google Scholar
• Huang J, Pan H, Wang J, et al. Unfolded protein response in colorectal cancer. Cell Biosci. 2021;11(1):26. doi:10.1186/s13578-021-00538-z
   PubMed Web of Science ®Google Scholar
• Okada K, Minamino T, Tsukamoto Y, et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation. 2004;110(6):705–712. doi:10.1161/01.CIR.0000137836.95625.D4
   PubMed Web of Science ®Google Scholar
• Zhuo XZ, Wu Y, Ni YJ, et al. Isoproterenol instigates cardiomyocyte apoptosis and heart failure via AMPK inactivation-mediated endoplasmic reticulum stress. Apoptosis. 2013;18(7):800–810. doi:10.1007/s10495-013-0843-5
   PubMed Web of Science ®Google Scholar
• Xu L, Cai Y, Wang Y, Xu C. Meteorin-Like (METRNL) Attenuates Myocardial Ischemia/Reperfusion Injury-Induced Cardiomyocytes Apoptosis by Alleviating Endoplasmic Reticulum Stress via Activation of AMPK-PAK2 Signaling in H9C2 Cells. Med Sci Monit. 2020;26:e924564. doi:10.12659/MSM.924564
   PubMed Web of Science ®Google Scholar
• Park HW, Park H, Ro SH, et al. Hepatoprotective role of Sestrin2 against chronic ER stress. Nat Commun. 2014;5:4233. doi:10.1038/ncomms5233
   PubMed Web of Science ®Google Scholar
• Wu X, Li Y, Zhang S, Zhou X. Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 2021;11(7):3052–3059. doi:10.7150/thno.54113
   PubMed Web of Science ®Google Scholar
• Lillo-Moya J, Rojas-Solé C, Muñoz-Salamanca D, Panieri E, Saso L, Rodrigo R. Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury. Antioxidants (Basel). 2021;10(5):667. doi:10.3390/antiox10050667
   PubMedGoogle Scholar
• Park TJ, Park JH, Lee GS, et al. Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes. Cell Death Dis. 2019;10(11):835. doi:10.1038/s41419-019-2061-8
   PubMed Web of Science ®Google Scholar
• Tonelli C, Chio IIC, Tuveson DA. Transcriptional Regulation by Nrf2. Antioxid Redox Signal. 2018;29(17):1727–1745. doi:10.1089/ars.2017.7342
   PubMed Web of Science ®Google Scholar
• Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev. 2006;38(4):769–789. doi:10.1080/03602530600971974
   PubMed Web of Science ®Google Scholar
• Lu H, Xiao H, Dai M, et al. Britanin relieves ferroptosis-mediated myocardial ischaemia/reperfusion damage by upregulating GPX4 through activation of AMPK/GSK3β/Nrf2 signalling. Pharm Biol. 2022;60(1):38–45. doi:10.1080/13880209.2021.2007269
   PubMed Web of Science ®Google Scholar
• Wu Y, Fan Z, Chen Z, et al. Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a. Mol Cell Biochem. 2020;470(1–2):41–51. doi:10.1007/s11010-020-03743-5
   PubMed Web of Science ®Google Scholar
• Xia ML, Xie XH, Ding JH, et al. Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease. J Neuroinflammation. 2020;17(1):105. doi:10.1186/s12974-020-01791-8
   PubMed Web of Science ®Google Scholar
• Song J, Yangqian H, Jian L, et al. Effects of astragalus polysaccharide on myocardial AMPK activity and FFA metabolism in rats with chronic heart failure. Chin J Pathophysiol. 2015;31(01):28–32.
   Google Scholar
• Xinwei R, Weiguo Z, Yuzhen N. Mechanism of action of astragaloside on mitochondrial autophagy in rat cardiomyocytes with acute heart failure via CaMkkβ/AMPK pathway. J Med Forum. 2023;44(09):41–46.
   Google Scholar
• Hao-yu L, Xing-jun X, Xue-han L, et al. Effects of total flavonoids of Luo Han Guo on antioxidant capacity and inflammatory response in mice with chronic sleep deprivation. J Animal Nutr. 2023;35(07):4668–4677.
   Google Scholar
• Weibin M, Mingming G, Ting L, et al. Effects of Rosmarinus officinalis flavonoids on myocardial energy metabolising enzymes and PPARα mRNA expression in exercising rats. Chin J Exp Formulas. 2013;19(14):203–208.
   Google Scholar
• Luoqi Z, Sen L, Ruyi C, et al. Interaction of ginsenosides with MAPK signalling pathway based on SPRi technology and molecular docking. Chin Patent Med. 2023;45(09):3123–3127.
   Google Scholar
• Kong HL, Hou AJ, Liu NN, Chen BH, Dai SN, Huang HT. The effects of ginsenoside Rb1 on fatty acid β-oxidation, mediated by AMPK, in the failing heart. Iran J Basic Med Sci. 2018;21(7):731–737. doi:10.22038/IJBMS.2018.24002.6016
   PubMed Web of Science ®Google Scholar
• Qingrui S, Xiaojun Z, Weide Z, Houang L, Jianzhe L. Progress of cardioprotective effect and mechanism of action of paeoniflorin. Zhongnan Pharmacol. 2023;21(09):2386–2391.
   Google Scholar
• Yuqin G, Jiping H, Guoping Z. Protective effect of AMPKα activation by paeoniflorin pretreatment on myocardial ischaemia-reperfusion injury in in vivo rats. Hainan Med. 2015;26(15):2185–2189.
   Google Scholar
• Keran F, Weixia L, Xiaoyan W, et al. Predictive analyses of chemical constituents, pharmacological effects and their quality markers (Q-Marker) of Salvia miltiorrhiza. Chin Herbal Med. 2022;53(02):609–618.
   Google Scholar
• Zhang X, Wang Q, Wang X, et al. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway. Biomed Pharmacother. 2019;112:108599. doi:10.1016/j.biopha.2019.108599
   PubMed Web of Science ®Google Scholar
• Xiaolian L, Jianlian L, Wenli L, et al. Progress of pharmacological effects and clinical application of total saponins of Panax ginseng. Hubei Agri Sci. 2021;60(06):15–19.
   Google Scholar
• Wang D, Lv L, Xu Y, et al. Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy. Biomed Pharmacother. 2021;136:111287. doi:10.1016/j.biopha.2021.111287
   PubMed Web of Science ®Google Scholar
• Zhi-Cong Z, Feng-Hsia L, Yuan-Gui Z, et al. Mechanism study of berberine-mediated LncRNA-MIAT regulation of autophagy to inhibit cardiomyocyte hypertrophy. World Sci Technol Modern Trad Chin Med. 2019;21(10):2113–2120.
   Google Scholar
• Zhou B, Zhang J, Chen Y, et al. Puerarin protects against sepsis-induced myocardial injury through AMPK-mediated ferroptosis signaling. Aging (Albany NY). 2022;14(8):3617–3632. doi:10.18632/aging.204033
   PubMedGoogle Scholar
• Ma ZG, Dai J, Zhang WB, et al. Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathway. Br J Pharmacol. 2016;173(9):1502–1516. doi:10.1111/bph.13449
   PubMed Web of Science ®Google Scholar
• De-You J, Wan-Qiu Z, Jie-Ru H. Research progress of Ling Gui Zhu Gan Tang. J Chin Med. 2021;36(12):2562–2567.
   Google Scholar
• Peng Z, Jinling J. Progress of clinical application and pharmacological effects of Ling Gui Zhu Gan Tang in the prevention and treatment of chronic heart failure. Shizhen Guojian Guojian. 2018;29(09):2231–2233.
   Google Scholar
• Juan Y, Rui D, Xiangyang L, et al. Effects of Ling Gui Zhu Gan Tang on mitochondrial fission-fusion and Sirt3/AMPK signalling pathway in post-infarction chronic heart failure rats. Chin J Exp Formulas. 1–9. doi:10.13422/j.cnki.syfjx.20231004
   Google Scholar
• Jiaming W, Yuying L, Jialing L, et al. Effects of effective components of Yixintai on CaN in myocardial tissue of rabbits with chronic heart failure. Chin Pharmacol Bull. 2021;37(10):1457–1463.
   Google Scholar
• Yun T, Yang L. Effects of Yixintai granules on myocardial AMPK protein expression in rats with chronic heart failure with cardiac qi deficiency and blood stasis and water stagnation. Chin Med Introd. 2021;27(03):19–22.
   Google Scholar
• Yun T, Zhi-Hua G, Tong-Yu Z, et al. Effects of Yixintai alcoholic extract on angiotensin II-induced Bax and Bcl-2 protein expression in rabbit cardiac fibroblasts. China J Trad Chin Med Infor. 2021;28(08):83–86.
   Google Scholar
• Xian SX, Yang ZQ, Ren PH, et al. Effect of yangxinkang tablets on chronic heart failure: a multi-center randomized double-blind placebo-controlled trial. Chin J Integr Med. 2015;21(10):733–742. doi:10.1007/s11655-015-2170-x
   PubMed Web of Science ®Google Scholar
• Ren PH, Zhang ZM, Wang P, Zhu HP, Li ZQ. Yangxinkang tablet protects against cardiac dysfunction and remodelling after myocardial infarction in rats through inhibition of AMPK/mTOR-mediated autophagy. Pharm Biol. 2020;58(1):321–327. doi:10.1080/13880209.2020.1748662
   PubMed Web of Science ®Google Scholar
• Gang S, Jianling Z, Zhiyi W, et al. Clinical study of heart failure ning for treating chronic heart failure of cardiac and renal yang deficiency type. Shizhen Guomao Guomao. 2017;28(11):2686–2687.
   Google Scholar
• Jinhong W, Gang S. Observation on the efficacy of heart failure ning on chronic moderate and severe heart failure. Liaoning J Chin Med. 2014;41(12):2613–2614.
   Google Scholar
• Yuanli H, Zhenxiang A, Ruilin Y, et al. Effects of heart failure granules on transforming growth factor β1 in myocardial tissue of rats with chronic heart failure. J Guiyang Coll Trad Chin Med. 2016;38(05):23–27.
   Google Scholar
• Zhen Z, Yongping Z. Effects of different dosage forms of Heart Failure Ning on haemodynamics. Chin J Exp Formulas. 2014;20(13):169–171.
   Google Scholar
• Yuanli H, Zhenxiang A, Ruilin Y, Lei G. Effects of Heart Failure Ning Combination on myocardial AMPK and PPARα in rats with chronic heart failure. New Chin Med Clin Pharmacol. 2020;31(03):287–293.
   Google Scholar
• Chenghao C, Lihua H, Huichao Z. Pharmacological mechanism of Wen Yang Yi Qi formula for improving post-infarction heart failure in rats based on AMPK-mediated mitochondrial autophagy analysis. Chin J Comp Med. 2019;29(12):39–44.
   Google Scholar
• Xiaomin H, Zhengxu F, Meiying H. Clinical observation on the treatment of chronic heart failure with tonifying yang and returning five soups. Guangming Trad Chin Med. 2021;36(15):2551–2553.
   Google Scholar
• Zhen W, Jiebai L, Xin D, Xiaoxu S. Effects of tonifying Yang and restoring Wu Tang on myocardial mitochondrial energy metabolism and AMPK/PPARα signalling pathway in rats with diastolic heart failure. Chin J Exp Formulas. 2019;25(09):12–17.
   Google Scholar
• Shihai Y, Huihua F, Lei T, Qiyi L. Exploring the mechanism of improving myocardial mitochondrial damage in chronic heart failure by shenkui tongwei granules based on AMPK-mt TFA-PINK1 signalling. New Chin Med Clin Pharmacol. 2018;29(06):738–743.
   Google Scholar
• Fan Z, Wei F, Guangli Z. Effects of ginseng and cardiotonic combination on AMPK-PGC-1α pathway of myocardial energy metabolism in heart failure rats. Zhejiang J Integr Chin West Med. 2018;28(10):834–837.
   Google Scholar
• Wei Z, Yuanwang Y, Shuzhen Z, et al. Effects of ginseng and ligusticum formula on myocardial energy metabolism in rats with heart failure model after myocardial infarction. J Changchun Univ Trad Chin Med. 2018;34(03):415–418.
   Google Scholar
• Xianwei W, Wenfeng S, Xiaoxiao Y, et al. Effects of Huanglian detoxification soup on adenylate-activated protein kinase and intercellular adhesion molecule-1 in inflammation-injured endothelial cells. J Xinxiang Med Coll. 2014;31(07):513–516.
   Google Scholar
• Qiong H, Shanning Y, Lijun J. Experimental study on the protective effect of ginseng and sorrel injection on chronic heart failure in rats. Mod Clin Med. 2012;38(03):173–175.
   Google Scholar